Jorge J. Castillo, MD, clinical director, Bing Center for Waldenström Macroglobulinemia, institute physician, Dana-Farber Cancer Institute, associate professor, medicine, Harvard Medical School, discusses the efficacy of treatment with iopofosine I 131 (previously CLR 131) in patients with Waldenström macroglobulinemia.

https://www.onclive.com/view/dr-castillo-on-the-efficacy-of-iopofosine-i-131-in-waldenstr-m-macroglobulinemia